GC Biopharma receives $10 million worth of ‘GCFLU’ order from Thailand

COMPANY / Reporter Paul Lee / 2023-11-24 00:20:46

 

[Alpha Biz=(Chicago) Reporter Paul Lee] GC Biopharma said on the 23rd that its flu vaccine "GCFLU" has won an order worth about $10 million in a 2024 bid for Thailand's state-run pharmaceutical company GPO (Government Pharmaceutical Organization).

This is the largest amount GC Biopharma has signed since entering the Thai flu vaccine market in 2014. The company explained that the terms and conditions of the contract, such as the contract amount and period, could change in the future following an agreement with the other country.

Meanwhile, GC Biopharma is the largest supplier of seasonal flu vaccines for an international organization under the WHO, which supplies flu vaccines to 63 countries around the world. So far, the cumulative production of the flu vaccine has exceeded 300 million doses.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally
뉴스댓글 >

SNS